Breaking News Instant updates and real-time market news.

TNXP

Tonix Pharmaceuticals

$3.66

0.03 (0.83%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04

Tonix: Horsepox virus showed protection vs. lethal vaccinia infection in study

Tonix Pharmaceuticals Holding announced the publication of research describing the successful synthesis and characterization of a potential smallpox-preventing vaccine based on horsepox virus. The research was conducted in conjunction with scientists from the University of Alberta, a leading Canadian research university. The peer-reviewed article, "Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments published in the journal PLOS ONE, follows the announcement in March of 2017 of the complete synthesis of horsepox virus using synthetic biology technology. The synthetic horsepox virus demonstrated the ability to protect against lethal vaccinia infection in a mouse model which may be indicative of vaccine protection in humans. Tonix is developing the synthetic version of horsepox virus from cell culture, designated TNX-801, as a potential vaccine to prevent smallpox infection in humans. TNX-801 is at pre-Investigational New Drug application stage.

TNXP Tonix Pharmaceuticals
$3.66

0.03 (0.83%)

08/18/17
ROTH
08/18/17
UPGRADE
ROTH
Buy
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
08/18/17
ROTH
08/18/17
UPGRADE
ROTH
Buy
Tonix Pharmaceuticals upgraded to Buy on valuation at Roth Capital
As previously reported, Roth Capital upgraded Tonix to Buy from Neutral with a price target of $6. Analyst Scott Henry believes Tonix's current valuation does not reflect the potential of the Tonmya program to treat PTSD and said the company has the cash runway to reach pivotal data readout in both first half 2018 and second half 2018. Additionally, the analyst said the AtEase trial has a reasonable chance for success with the higher 5 6 mg dose.
08/18/17
08/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Rentals (URI) upgraded to Buy from Hold at Stifel with analyst Stanley Elliott saying that the company's acquisition of Neff (NEFF) increases his confidence in its outlook and leaves it better positioned to exploit favorable demand trends. 2. Tonix Pharmaceuticals (TNXP) upgraded to Buy from Neutral at Roth Capital with analyst Scott Henry believes Tonix's current valuation does not reflect the potential of the Tonmya program to treat PTSD and said the company has the cash runway to reach pivotal data readout in both first half 2018 and second half 2018. 3. Quanta Services (PWR) and MasTec (MTZ) were upgraded to Buy from Neutral at Citi. 4. Howard Bancorp (HBMD) upgraded to Overweight from Equal Weight at Stephens with analyst Austin Nicholas saying the in-market acquisition of 1st Mariner strategically deploys Howard's excess capital, creating the #1 community bank in Baltimore. 5. Myriad Genetics (MYGN) upgraded to Hold from Sell at Deutsche Bank with analyst Dan Leonard saying the risk/reward is now balanced following the company's weaker than expected FY18 outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/22/17
DRXL
08/22/17
INITIATION
Target $9
DRXL
Buy
Tonix Pharmaceuticals initiated with a Buy at Drexel Hamilton
Drexel Hamilton initiated Tonix Pharmaceuticals with a Buy and a $9 price target.

TODAY'S FREE FLY STORIES

NCR

NCR Corp.

$32.23

0.06 (0.19%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
NCR Corp. announces strategic alliance with TCS »

NCR Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$20.17

0.14 (0.70%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Syndicate
Easterly Government Properties 18M share Spot Secondary priced at $19.25 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CLBS

Caladrius

$4.05

-0.015 (-0.37%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Caladrius receives FDA RMAT designation for CD34+ cell therapy »

Caladrius Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPO

China Biologic

$99.29

17.39 (21.23%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
China Biologic receives acquisition proposal from CCRE for $110 cash per share »

China Biologic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$114.10

0.215 (0.19%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Initiation
XPO Logistics initiated  »

XPO Logistics resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREX

Trex Company

$64.61

1.675 (2.66%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Trex Company announces effectiveness of 2-for-1 stock split »

Trex Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.84

-0.095 (-0.31%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Hot Stocks
Genpact awarded patent for natural language understanding by USPTO »

Genpact announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULH

Universal Logistics

$26.50

0.15 (0.57%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Initiation
Universal Logistics initiated  »

Universal Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

LSTR

Landstar System

$115.30

0.25 (0.22%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Landstar System initiated  »

Landstar System resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$49.15

0.3 (0.61%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Recommendations
Mirati Therapeutics analyst commentary  »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

ECHO

Echo Global

$30.40

-0.15 (-0.49%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Echo Global initiated  »

Echo Global resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

CHRW

C.H. Robinson

$90.67

0.57 (0.63%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Initiation
C.H. Robinson initiated  »

C.H. Robinson resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

TTPH

Tetraphase

$4.20

-0.05 (-1.18%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Conference/Events
Tetraphase has a conference call hosted by SunTrust »

SunTrust will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

  • 28

    Aug

BTE

Baytex Energy

$3.40

-0.47 (-12.16%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Upgrade
Baytex Energy rating change  »

Baytex Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.05

(0.00%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Recommendations
Snap analyst commentary  »

Snap survey shows usage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
06/19/18
06/19
07:55
06/19/18
07:55
General news
U.S. chain store sales rose 1.4% in the week ended June 16 »

U.S. chain store sales…

HSGX

Histogenics

$2.87

-0.1 (-3.37%)

07:55
06/19/18
06/19
07:55
06/19/18
07:55
Conference/Events
Histogenics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TDG

TransDigm

$340.12

0.06 (0.02%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Recommendations
TransDigm analyst commentary  »

TransDigm poised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

, BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Downgrade
Madrigal Pharmaceuticals, Bristol-Myers, Nektar rating change  »

Madrigal cut to In Line…

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

NKTR

Nektar

$58.40

0.545 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

RHT

Red Hat

$176.26

1.27 (0.73%)

07:53
06/19/18
06/19
07:53
06/19/18
07:53
Downgrade
Red Hat rating change  »

Red Hat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GLT

Glatfelter

$18.95

0.1 (0.53%)

07:49
06/19/18
06/19
07:49
06/19/18
07:49
Hot Stocks
Glatfelter to acquire Georgia-Pacific's European nonwovens business for $185M »

Glatfelter announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

, CELG

Celgene

$77.71

-0.38 (-0.49%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Upgrade
Bluebird Bio, Celgene rating change  »

Bluebird Bio upgraded to…

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

CELG

Celgene

$77.71

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBSV

ObsEva

$17.21

2.68 (18.44%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Recommendations
ObsEva analyst commentary  »

ObsEva price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DLAKY

Lufthansa

$0.00

(0.00%)

, NWARF

Norwegian Air Shuttle

$0.00

(0.00%)

07:44
06/19/18
06/19
07:44
06/19/18
07:44
Periodicals
Norwegian Air says takeover bids go beyond Lufthansa, IAG, Bloomberg reports »

Norwegian Air Shuttle…

DLAKY

Lufthansa

$0.00

(0.00%)

NWARF

Norwegian Air Shuttle

$0.00

(0.00%)

ICAGY

IAG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$47.46

-0.59 (-1.23%)

, TMUS

T-Mobile

$60.37

0.37 (0.62%)

07:44
06/19/18
06/19
07:44
06/19/18
07:44
Upgrade
Verizon, T-Mobile, Sprint rating change  »

Deutsche sees 23% total…

VZ

Verizon

$47.46

-0.59 (-1.23%)

TMUS

T-Mobile

$60.37

0.37 (0.62%)

S

Sprint

$5.55

0.055 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.